Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens.

Justin De La CruzSaran VardhanbhutiMalaya K SahooRobert RovnerRonald J BoschJusten ManasaDavid A KatzensteinBenjamin A Pinsky

Published in: Open forum infectious diseases (2019)

Persistence of RTI mutations in proviral DNA after virologic failure has implications for the effectiveness of future drug regimens and the recycling of RTI drugs.

Keyphrases

human immunodeficiency virus
antiretroviral therapy
hiv infected
hiv infected patients
hiv positive
hiv aids
randomized controlled trial
systematic review
circulating tumor
hepatitis c virus
current status
single molecule
adverse drug
hiv testing
men who have sex with men